Stay updated with breaking news from Stroke Conference. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Athersys, Inc. , a regenerative medicine company developing MultiStem® cell therapy for critical care indications, announced on Monday, May 15th financial results for the three months ended... | May 18, 2023
A new study provides evidence for better functional recovery after endovascular therapy from a population of large-infarction strokes that could contribute to changing clinical practice.
The drug, butylphthalide, was associated with better outcomes after ischemic stroke after thrombolysis or endovascular therapy.
Preliminary results of a new study showed that using an antihypertensive drug to target systolic blood pressure to below 160 mm Hg or 140 mm Hg in these patients may not be beneficial, and may even be harmful.
A new international trial has shown large benefits of thrombectomy in patients with ischemic strokes with a large core volume, which should lead to a change in clinical practice.